GeneDx Holdings $WGS Read from its own SEC filings · nothing written, nothing inferred
🫧 Edgar looked up GeneDx Holdings Corp. ($WGS). Last filing: 10-Q, 2026-08-03. 8 event filings (8-K) in the past twelve months.
🔖 Exposure: revenue $427.5M (FY2025), total debt $54.5M. Experience: revenue up 40.0% on the year, up 19.1% a year over 4 years; operating margin -3.1%, up from -7.6%. Soundness: equity 58.8% of assets, return on equity -6.8%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $401.9M and $755.2M next year (method v4.1: its own 4-year record of growth weighed at 50% against $100M–1B filers; on a year the method never saw, 83.4% landed inside). In a shock year the stress range is $342.7M to $891.6M. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, services-health services): operating margin -3.1% against a -3.3% median; growth 40.0% against 19.2%.
Speed and cash · fiscal 2025
Both views must agree for a label · a description, not advice.
| Cash flow (op · inv · fin · free) | $33M · −$62M · $48M · $14M |
| Investment book (cash · short · long) | $105M · $66M · — · current ratio 2.46 |
| Revenue swing · equity of assets | 25.2% · 58.9% |
GeneDx Holdings is growing faster than its size class, with revenue that swings more. Its own audited SEC figures.
The figures, as filed
| Fiscal year end | 2025-12-31 |
| Revenue | $428M |
| Revenue, on the year | 40.0% |
| Revenue, a year over the record | 19.1% |
| Operating margin | −3.1% |
| Operating margin, prior year | −7.6% |
| Net margin | −4.9% |
| Research and development | $72M · 16.8% of revenue |
| Total debt | $55M |
| Equity of assets | 58.8% |
| Return on equity | −6.8% |
| Payout of profit | — |
| Dividend per share | — |
| Earnings per share | $-0.73 |
| Book value per share | $10.76 |
| Revenue per share | $14.93 |
| Shares outstanding | 28,641,734 |
| Audited years read | 5 |
Peers: the median of 10 filers with $50M+ revenue in services-health services.
Health HarborGeneDx Holdings sails as: Sound ship
Health watch · 12 monthsDirector or officer change
Sailing speed follows growth: 22.1% a year crosses the harbor in 30 seconds.
🌊 Visit the Bay →- revenue is hard to predict: its 80% range is ±31%
Boat condition = number of warning signs: a serious warning filing in 12 months; liabilities over assets; slow and jumpy; negative operating cash; an 80% revenue range of ±25% or wider. A picture of the signs, not a rating and not investment advice.
- 10-Q · 2026-08-03
- 8-K · 2026-08-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits
- 8-K · 2026-06-23 · 5.07 Submission of Matters to a Vote of Security Holders
- 8-K · 2026-06-16 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits
- 10-Q · 2026-05-04
- 8-K · 2026-05-04 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits
Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price. Reporting, not investment advice. No price targets and no trading recommendations. Figures from the SEC’s own data · every filing · this page as JSON · ask about another company